Class 2 Drug Alert: Nacrez (Desogestrel)

Teva UK Limited is recalling batches of Nacrez 75 microgram Film-coated Tablets (Desogestrel) due to out of specification results for impurities obtained during routine stability testing. 

No complaints relating to this issue have been received by the company to date.

Women currently using this product are advised to finish the pack and if they have any concerns they should speak to their doctor or pharmacist.

Remaining stock of these batches should be quarantined and returned to the original supplier for credit.

To read the alert in full, visit the MHRA website.


Latest discussions

  1. Pre reg exams

    Thanks for your comments both - Richard ...

  2. Pre reg exams

    Having been qualified just over 40 years...

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.